James T. LaFrance
Director/Board Member at Personal Genome Diagnostics, Inc.
Profile
James T.
LaFrance is the founder of Lafrance Consulting LLC, which was founded in 2009.
He served as the President & Chief Executive Officer from 2009 to 2011.
Currently, he holds two positions as an Independent Director at Personal Genome Diagnostics, Inc. since 2017 and as a Director at LightIntegra Technology, Inc. since 2018.
In the past, he served as the Chief Executive Officer at Omnyx LLC from 2012 to 2013, Chief Executive Officer at Vermilion, Inc., Lead Independent Director at Aspira Women's Health, Inc. from 2013 to 2022, Independent Director at HTG Molecular Diagnostics, Inc. from 2015 to 2022, and Director at MDNA Life Sciences, Inc. from 2010 to 2011.
He also served as a Director at Bioarray Genetics, Inc. and as the General Manager at Ventana Medical Systems, Inc. from 2001 to 2009.
Mr. LaFrance holds an MBA degree from the University of Notre Dame and an undergraduate degree from the University of Connecticut.
James T. LaFrance active positions
| Companies | Position | Start |
|---|---|---|
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Director/Board Member | 01/04/2017 |
LightIntegra Technology, Inc.
 LightIntegra Technology, Inc. Medical SpecialtiesHealth Technology LightIntegra Technology, Inc. develops medical device that analyzes the quality of platelets. It offers ThromboLUX, a medical device that characterizes platelet suspensions with a score reflecting the quantity of platelets, microparticles and other particles in the suspension. The company was founded in 2008 by Elisabeth Maurer-Spurej and is headquartered in Vancouver, Canada. | Director/Board Member | 06/02/2018 |
Former positions of James T. LaFrance
| Companies | Position | End |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Chief Executive Officer | 31/12/2014 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Director/Board Member | 18/08/2022 |
Omnyx LLC
 Omnyx LLC Medical/Nursing ServicesHealth Services Omnyx LLC provides digital pathology workflow solutions. The firm delivers new digital pathology solutions for diagnostic medicine, and software and transformative consulting. The company is headquartered in Pittsburgh, PA. | Chief Executive Officer | 01/09/2013 |
| Lafrance Consulting LLC | Chief Executive Officer | 01/01/2011 |
MDNA Life Sciences, Inc.
 MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Director/Board Member | 01/01/2011 |
Training of James T. LaFrance
| University of Notre Dame | Masters Business Admin |
| University of Connecticut | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
 | Health Services |
| Private companies | 7 |
|---|---|
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Health Technology |
LightIntegra Technology, Inc.
LightIntegra Technology, Inc. Medical SpecialtiesHealth Technology LightIntegra Technology, Inc. develops medical device that analyzes the quality of platelets. It offers ThromboLUX, a medical device that characterizes platelet suspensions with a score reflecting the quantity of platelets, microparticles and other particles in the suspension. The company was founded in 2008 by Elisabeth Maurer-Spurej and is headquartered in Vancouver, Canada. | Health Technology |
Bioarray Genetics, Inc.
 Bioarray Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Bioarray Genetics, Inc. develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments. It also develops proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used. The company was founded by Marcia Fournier and Katherine J. Martin in 2009 and is headquartered in Farmington, CT. | Commercial Services |
| Lafrance Consulting LLC | |
Omnyx LLC
Omnyx LLC Medical/Nursing ServicesHealth Services Omnyx LLC provides digital pathology workflow solutions. The firm delivers new digital pathology solutions for diagnostic medicine, and software and transformative consulting. The company is headquartered in Pittsburgh, PA. | Health Services |
Vermilion, Inc.
 Vermilion, Inc. Advertising/Marketing ServicesCommercial Services Vermilion, Inc. is an international energy producer that focuses on acquiring, exploring, developing, and optimizing producing assets in various countries. Vermilion is based in Boulder, CO. The private company's business model emphasizes free cash flow generation and returning capital to investors when economically warranted, augmented by value-adding acquisitions. Vermilion's operations are focused on the exploitation of light oil and liquids-rich natural gas conventional resource plays in Canada and the exploration and development of conventional natural gas and oil opportunities in France and Australia. The company prioritizes health and safety, the environment, and profitability, in that order. The company was founded by Bob Morehouse, and Susan Touchette Aust has been the CEO of the company since 1992. | Commercial Services |
- Stock Market
- Insiders
- James T. LaFrance
